VIXXA
LIVE

Serial Number

79426642

Owner

GlucoRx Ltd

Attorney

M. David Galin

Filing Date

Feb 26, 2025

Add to watchlist:

No watchlists yet
View on USPTO

VIXXA Trademark

Serial Number: 79426642 • Registration: 8105889

VIXXA is a trademark filed by GlucoRx Ltd on February 26, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

GlucoRx Ltd (4 trademarks)

Unit 1c Henley Business Park,

Entity Type: 99

Trademark Details

Filing Date

February 26, 2025

Registration Date

January 20, 2026

Published for Opposition

December 2, 2025

Goods & Services

Online advertising on a computer network; advertising services; commercial administration of the licensing of the goods and services of others; providing business information via a website; sales promotion for others; provision of an online marketplace for buyers and sellers of goods and services; import-export agency services; updating and maintenance of data in computer databases; wholesale and retail store services featuring pharmaceuticals; business auditing

Medical devices for medical and surgical use, namely, medical test kits for diabetes monitoring; medical, weight management, lifestyle and wellness devices for human and veterinary purposes, namely, electrical weight loss body belt, therapeutic compression wraps; sensors that are implanted or inserted into the body used to continuously monitor the concentration of physiological analytes in the body for medical purposes; non-invasive sensors that are used to continuously monitor the concentration of physiological analytes in the body and associated accessories, namely, receivers, sensor housings and sensor insertion devices, all for medical purposes; medical apparatus and instruments, namely, blood pressure monitors, blood glucose monitors; analytes measuring meters, namely, blood glucose meters; pumps for medical purposes, namely, pumps for use in delivering pharmaceuticals from containers; medical apparatus for monitoring vital signs of patients; patient monitoring sensors and alarms for medical purposes; cytometers for medical diagnostic use; patient examination tables; diagnostic apparatus for medical use, namely, ultrasound diagnostic apparatus, glucose monitoring apparatus; medical apparatus and instruments for monitoring electrocardiography, carbon dioxide levels, oxygen saturation, exercise and activity heart rates, cardiac activity, and respiratory events; pulse meters, heart rate monitoring apparatus and body composition monitors

Test strips for measuring blood glucose levels; diagnostic preparations for medical purposes; nutraceutical preparations for therapeutic or medical purposes, namely, for the treatment of diabetes; pharmaceutical preparations for the treatment of managing blood sugar levels and diabetes; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for treating diabetes; anti-diabetic pharmaceuticals; anti-diabetic preparations; dietetic foods adapted for medical purposes; veterinary diagnostic reagents; medical diagnostic reagents; reagents for use in metabolic syndrome diagnostic tests for medical purposes; massage creams for medical purposes; insulin injectors sold filled with insulin; analytes test strips, namely, medical diagnostic test strips for blood analysis, medical diagnostic test strips for urine analysis

Downloadable computer software for use by one or more individuals to acquire, receive, store, process, analyse, access, present, report and transmit medical and physiological data; downloadable software applications for mobile devices for monitoring and managing patient medical information; apparatus and instruments for receiving and storing sound and data in digital form, namely, digital computers, computer hardware; recorded computer software for monitoring an individual's blood pressure, weight, heart rate and respiratory events; downloadable computer software using artificial intelligence for machine learning in the field of healthcare; recorded computer software using artificial intelligence for remote monitoring of medical data for medical diagnosis and treatment

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 20, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 20, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 20, 2026 R.PR
NOTIFICATION PROCESSED BY IB
Dec 19, 2025 GPNX
CORRECTION TRANSACTION RECEIVED FROM IB
Dec 18, 2025 CRCV
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 2, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 2, 2025 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 26, 2025 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 26, 2025 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 25, 2025 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 4, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 8, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 8, 2025 TROA
REFUSAL PROCESSED BY IB
Oct 3, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 10, 2025 RFCS
REFUSAL PROCESSED BY MPU
Sep 10, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 1, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jul 31, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 31, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 7, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 30, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 26, 2025 REPR